Inhaled Bronchodilator Association and Quality of Life in Patients With Chronic Obstructive Pulmonary Disease

Boehringer Ingelheim

Status: Completed

Conditions: Pulmonary Disease, Chronic Obstructive

Treatments: Drug: inhaled bronchodilator

Study type: Observational

Funder types: Industry

Identifiers

NCT02176564

1012.40

Details and patient eligibility

About

A pharmaco-epidemiological, observational study that aimed at assessing in a prospective manner the evolution of Quality of Life (QOL) in chronic obstructive pulmonary disease (COPD) patients treated with inhaled bronchodilators

Enrollment: 2,639 patients

Sex: All

Volunteers: No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria:

• Diagnosis of COPD confirmed by Pulmonary Function Test (PFTs)
• Recent treatment with a free or fixed association of inhaled bronchodilators

Trial design

2,639 participants in 1 patient group

Chronic obstructive pulmonary disease

Description:

Patients with COPD treated with inhaled bronchodilators

Treatment:

Drug: inhaled bronchodilator